The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, LifeStance Health Group Inc (NASDAQ: LFST) closed at $4.66 up 1.97% from its previous closing price of $4.57. In other words, the price has increased by $1.97 from its previous closing price. On the day, 3.05 million shares were traded. LFST stock price reached its highest trading level at $4.725 during the session, while it also had its lowest trading level at $4.52.
Ratios:
For a deeper understanding of LifeStance Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.09. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 1.48. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on July 25, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On May 27, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $8.50.
On April 08, 2025, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $9.KeyBanc Capital Markets initiated its Overweight rating on April 08, 2025, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 08 ’25 when Burdick Kenneth A bought 47,670 shares for $4.36 per share. The transaction valued at 207,751 led to the insider holds 3,416,571 shares of the business.
Burdick Kenneth A bought 46,511 shares of LFST for $199,997 on Aug 08 ’25. The Director now owns 46,511 shares after completing the transaction at $4.30 per share. On Aug 11 ’25, another insider, Burdick Kenneth A, who serves as the Director of the company, bought 20,000 shares for $4.53 each. As a result, the insider paid 90,545 and bolstered with 3,436,571 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 1812441728 and an Enterprise Value of 2097272576. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 1.593 whereas that against EBITDA is 35.61.
Stock Price History:
The Beta on a monthly basis for LFST is 1.13, which has changed by -0.17957747 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.61, while it has fallen to a 52-week low of $3.74. The 50-Day Moving Average of the stock is -2.15%, while the 200-Day Moving Average is calculated to be -28.59%.
Shares Statistics:
For the past three months, LFST has traded an average of 2.31M shares per day and 3163950 over the past ten days. A total of 389.08M shares are outstanding, with a floating share count of 144.77M. Insiders hold about 62.78% of the company’s shares, while institutions hold 36.26% stake in the company. Shares short for LFST as of 1753920000 were 7412301 with a Short Ratio of 3.21, compared to 1751241600 on 8670558. Therefore, it implies a Short% of Shares Outstanding of 7412301 and a Short% of Float of 8.59.
Earnings Estimates
The market rating of LifeStance Health Group Inc (LFST) is currently shaped by the ongoing analysis conducted by 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.04, with high estimates of $0.04 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.17 and $0.17 for the fiscal current year, implying an average EPS of $0.17. EPS for the following year is $0.2, with 1.0 analysts recommending between $0.2 and $0.2.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $356.18M this quarter.It ranges from a high estimate of $357.8M to a low estimate of $354.9M. As of the current estimate, LifeStance Health Group Inc’s year-ago sales were $312.72MFor the next quarter, 6 analysts are estimating revenue of $378.31M. There is a high estimate of $382.71M for the next quarter, whereas the lowest estimate is $374.5M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.41B, resulting in an average revenue estimate of $1.41B. In the same quarter a year ago, actual revenue was $1.25BBased on 8 analysts’ estimates, the company’s revenue will be $1.62B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.58B.
